Dimeric 4-Aryl-1,4-Dihydropyridines: Development of a Third Class of Nonpeptidic HIV-1 Protease Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|2|3|235-245

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.2, Iss.3, 2002-06, pp. : 235-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors

By Hilgeroth A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 5, 2003-05 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite

Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors

By Hilgeroth A.   Billich A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 4, 2001-04 ,pp. : 367-374

Elsevier

Access to resources Recommend Favorite

Non-Peptidic HIV Protease Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. : 1097-1114

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 protease inhibitors in development

By Catamancio Simona La Seta   Rusconi Stefano  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 387-395

Informa Healthcare

Access to resources Recommend Favorite

Interactions of the Dimeric Triad of HIV-1 Aspartyl Protease with Inhibitors

By MAGER PETER   DE CLERCQ ERIK   FROEYEN MATHEUS   REINHARDT ROBERT  

Drug Design and Discovery, Vol. 18, Iss. 2-3, 2003-04 ,pp. : 53-64

Taylor & Francis Ltd

Access to resources Recommend Favorite